CN112843193A - Skin rejuvenation liquid for treating burns and scalds - Google Patents
Skin rejuvenation liquid for treating burns and scalds Download PDFInfo
- Publication number
- CN112843193A CN112843193A CN202011328397.9A CN202011328397A CN112843193A CN 112843193 A CN112843193 A CN 112843193A CN 202011328397 A CN202011328397 A CN 202011328397A CN 112843193 A CN112843193 A CN 112843193A
- Authority
- CN
- China
- Prior art keywords
- percent
- mixture
- chinese
- root
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003716 rejuvenation Effects 0.000 title claims abstract description 45
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 44
- 239000007788 liquid Substances 0.000 title claims description 31
- 239000000203 mixture Substances 0.000 claims description 78
- 238000003756 stirring Methods 0.000 claims description 61
- 239000003995 emulsifying agent Substances 0.000 claims description 30
- 235000019489 Almond oil Nutrition 0.000 claims description 25
- 239000004166 Lanolin Substances 0.000 claims description 25
- 239000008168 almond oil Substances 0.000 claims description 25
- 229940039717 lanolin Drugs 0.000 claims description 25
- 235000019388 lanolin Nutrition 0.000 claims description 25
- 239000003921 oil Substances 0.000 claims description 25
- 235000019198 oils Nutrition 0.000 claims description 25
- 239000004006 olive oil Substances 0.000 claims description 25
- 235000008390 olive oil Nutrition 0.000 claims description 25
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 24
- 238000001816 cooling Methods 0.000 claims description 23
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 21
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 21
- 241000783421 Corydalis saxicola Species 0.000 claims description 21
- 241000405414 Rehmannia Species 0.000 claims description 21
- 229910021538 borax Inorganic materials 0.000 claims description 21
- 229940116229 borneol Drugs 0.000 claims description 21
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 21
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 21
- 238000002156 mixing Methods 0.000 claims description 21
- 239000004328 sodium tetraborate Substances 0.000 claims description 21
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 21
- 230000001954 sterilising effect Effects 0.000 claims description 21
- 241001113925 Buddleja Species 0.000 claims description 20
- 240000003109 Persicaria chinensis Species 0.000 claims description 20
- 241000206469 Pulsatilla Species 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 229940064064 purslane extract Drugs 0.000 claims description 20
- 238000004659 sterilization and disinfection Methods 0.000 claims description 20
- 241000213006 Angelica dahurica Species 0.000 claims description 19
- 241001183967 Isodon Species 0.000 claims description 19
- 235000008599 Poria cocos Nutrition 0.000 claims description 19
- 244000197580 Poria cocos Species 0.000 claims description 19
- 239000000043 antiallergic agent Substances 0.000 claims description 18
- 239000007957 coemulsifier Substances 0.000 claims description 18
- 239000003974 emollient agent Substances 0.000 claims description 18
- 239000002562 thickening agent Substances 0.000 claims description 18
- 241000406668 Loxodonta cyclotis Species 0.000 claims description 17
- 240000006688 Telosma cordata Species 0.000 claims description 16
- 235000017352 Telosma cordata Nutrition 0.000 claims description 16
- 241000820163 Setaria leucopila Species 0.000 claims description 15
- 235000001155 Setaria leucopila Nutrition 0.000 claims description 15
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 14
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 14
- 229940106189 ceramide Drugs 0.000 claims description 14
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 14
- 229910052956 cinnabar Inorganic materials 0.000 claims description 14
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 14
- 240000001972 Gardenia jasminoides Species 0.000 claims description 13
- 241000270295 Serpentes Species 0.000 claims description 13
- 229940023569 palmate Drugs 0.000 claims description 13
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical group CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 12
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 12
- 240000006365 Vitis vinifera Species 0.000 claims description 12
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 12
- 229960000458 allantoin Drugs 0.000 claims description 12
- 230000001804 emulsifying effect Effects 0.000 claims description 12
- 239000003906 humectant Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 240000001579 Cirsium arvense Species 0.000 claims description 11
- 235000005918 Cirsium arvense Nutrition 0.000 claims description 11
- 241000246044 Sophora flavescens Species 0.000 claims description 10
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 10
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 10
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims description 9
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 229940107666 astragalus root Drugs 0.000 claims description 8
- 241000208296 Datura Species 0.000 claims description 7
- 244000111489 Gardenia augusta Species 0.000 claims description 7
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 6
- 241000382455 Angelica sinensis Species 0.000 claims description 6
- 241001671204 Stemona Species 0.000 claims description 6
- 241000029486 Stephania sinica Species 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 6
- 229930182478 glucoside Natural products 0.000 claims description 6
- 150000008131 glucosides Chemical class 0.000 claims description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical group CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- -1 polydimethylsiloxane Polymers 0.000 claims description 6
- 229940047670 sodium acrylate Drugs 0.000 claims description 6
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 claims description 6
- 240000008866 Ziziphus nummularia Species 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 241000723345 Chrysophyllum Species 0.000 claims description 4
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 244000040738 Sesamum orientale Species 0.000 claims description 4
- 244000044822 Simmondsia californica Species 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000000230 xanthan gum Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 229940082509 xanthan gum Drugs 0.000 claims description 4
- 235000010493 xanthan gum Nutrition 0.000 claims description 4
- 241001252483 Kalimeris Species 0.000 claims description 3
- 239000004264 Petrolatum Substances 0.000 claims description 3
- 235000019271 petrolatum Nutrition 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 claims description 3
- 241000563984 Ampelopsis Species 0.000 claims description 2
- 241000218176 Corydalis Species 0.000 claims description 2
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 2
- 244000248557 Ophiopogon japonicus Species 0.000 claims 4
- 229930195210 Ophiopogon Natural products 0.000 claims 3
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 claims 3
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 2
- 241000871539 Choerospondias Species 0.000 claims 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims 2
- 241001330502 Stephania Species 0.000 claims 2
- 244000137773 Viola philippica Species 0.000 claims 2
- 241000123835 Ampelopsis japonica Species 0.000 claims 1
- 241000132536 Cirsium Species 0.000 claims 1
- 241001022083 Flemingia Species 0.000 claims 1
- 244000018716 Impatiens biflora Species 0.000 claims 1
- 235000015912 Impatiens biflora Nutrition 0.000 claims 1
- 241000207925 Leonurus Species 0.000 claims 1
- 241000219000 Populus Species 0.000 claims 1
- 244000234609 Portulaca oleracea Species 0.000 claims 1
- 235000001855 Portulaca oleracea Nutrition 0.000 claims 1
- 241001671203 Stemona japonica Species 0.000 claims 1
- 244000204900 Talipariti tiliaceum Species 0.000 claims 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 208000002193 Pain Diseases 0.000 abstract description 18
- 230000036407 pain Effects 0.000 abstract description 18
- 231100000241 scar Toxicity 0.000 abstract description 9
- 230000035876 healing Effects 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 206010051548 Burn infection Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 206010020718 hyperplasia Diseases 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 239000006071 cream Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- 208000027418 Wounds and injury Diseases 0.000 description 18
- 206010052428 Wound Diseases 0.000 description 17
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 240000002948 Ophiopogon intermedius Species 0.000 description 11
- 208000014674 injury Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 230000008736 traumatic injury Effects 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 241000727913 Parthenocissus tricuspidata Species 0.000 description 7
- 206010042674 Swelling Diseases 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 241000205585 Aquilegia canadensis Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 6
- 229940104261 taurate Drugs 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241001018563 Nekemias grossedentata Species 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 244000308495 Potentilla anserina Species 0.000 description 4
- 235000016594 Potentilla anserina Nutrition 0.000 description 4
- 230000002924 anti-infective effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 239000009636 Huang Qi Substances 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000776115 Ampelopsis glandulosa var. brevipedunculata Species 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 241000037488 Coccoloba pubescens Species 0.000 description 2
- 241000876833 Emberizinae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010051814 Eschar Diseases 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 241000594394 Hedyotis Species 0.000 description 2
- 241000917703 Leia Species 0.000 description 2
- 241001377695 Polygonum arenastrum Species 0.000 description 2
- 235000010728 Polygonum aviculare subsp aviculare Nutrition 0.000 description 2
- 235000010105 Polygonum aviculare subsp depressum Nutrition 0.000 description 2
- 241001278099 Populus maximowiczii Species 0.000 description 2
- 241000736301 Pteridaceae Species 0.000 description 2
- 241000737259 Pteris vittata Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 240000004460 Tanacetum coccineum Species 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010058041 Wound sepsis Diseases 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 231100000333 eschar Toxicity 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000000651 myofibroblast Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000736299 Adiantum Species 0.000 description 1
- 235000013211 Adiantum capillus veneris Nutrition 0.000 description 1
- 244000005852 Adiantum capillus veneris Species 0.000 description 1
- 241000722826 Ardisia Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241001253169 Asystasia gangetica Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- 241001656898 Buxus microphylla Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000006069 Corneal Opacity Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001498082 Girardinia Species 0.000 description 1
- 240000000154 Girardinia diversifolia Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 244000158996 Hedysarum boreale Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 244000010000 Hovenia dulcis Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000132446 Inula Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000422392 Laurencia Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241001113846 Loganiaceae Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001453732 Odontosoria chinensis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 241000095444 Populus davidiana Species 0.000 description 1
- 241000737257 Pteris <genus> Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241000218998 Salicaceae Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241001369613 Stephania tetrandra Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000218215 Urticaceae Species 0.000 description 1
- 241001123668 Verticillium dahliae Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a skin rejuvenation cream for treating burns and scalds, which comprises the following components in parts by weight. The invention effectively prevents burn infection, relieves pain of the burn wound, promotes early healing of the wound, prevents scar hyperplasia and pruritus, has the functions of relieving pain and resisting infection, effectively accelerates the healing of the wound, solves the problem that no scar is left on the burn or scald, has good absorption effect, and is beneficial to timely relieving symptoms of patients.
Description
Technical Field
The invention relates to the technical field of repair liquid design, in particular to a skin rejuvenation repair liquid for treating burns and scalds.
Background
The skin is the largest barrier protection organ of the human body, and healthy skin can not only meet the beauty of people, but also prevent the invasion of external harmful substances and protect the stability of the internal environment of the human body. However, as environmental pollution becomes more serious, various problems such as dry skin, dull skin color, red blood streak, and sensitive skin occur to human skin, especially to facial skin exposed to air for the longest time. In order to deal with the skin problems, it is necessary to research and develop skin care products with certain repair functions, the skin is an important organ covering the surface of the human body and consists of epidermis, dermis, subcutaneous tissue and accessory organs of the skin, and the skin is a natural barrier between the external environment and the body and can effectively prevent external objects from directly invading into the body.
Burn mainly refers to the damage of skin, mucosa and even deep tissues caused by heat, chemical substances, electric energy, radioactive rays and the like, and the skin thermal burn is more common. The degree of burn varies with the temperature and the duration of action. Local variations can be divided into four degrees. First degree: congestion due to vascular paralysis; and a second degree: forming a serum-filled burn blister. (ii) a And a third degree: tissue necrosis; and fourth degree: charring the tissue. It is seen that the amount of lactic acid in blood increases and the pH value of arteriovenous blood decreases during burn, and the weight of the patient also increases with the aggravation of hypoxia blood disease caused by capillary dysfunction. Clinical experience has shown that burns can be life threatening when they reach more than one third of the total body surface area.
In the prior art, various medicines are used for treating burn. The medicines are dressing, aqua, ointment and the like, but most of the medicines have unsatisfactory curative effect, not only has long treatment course, but also can not remove scars, and most of the medicines for treating burn still suffer from the pain of skin grafting. In view of the related technical problems, no effective solution has been proposed at present.
Disclosure of Invention
The present invention provides a skin rejuvenation solution for treating burns and scalds, which is directed to the problems in the related art, so as to overcome the above technical problems in the related art.
The technical scheme of the invention is realized as follows:
a skin rejuvenation liquid for treating burns and scalds comprises, by weight, 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-2% of rehmannia root, 0.5-4% of radix ophiopogonis, 0.4-1% of radix stemonae, 0.1-1% of Chinese violet, 1-2% of cape jasmine, 1-3% of poria cocos, 0.4-1% of stephania sinica, 0.6-2% of palmate giraldii, 1-2% of corydalis saxicola, 1-3% of datura flower, 0.6-1% of field thistle, 0.4-1% of lineare herb, 0.5-1% of common knotweed herb, 2-8% of fern rhizome, 0.5-1% of Chinese inula herb, 0.1-1% of fingered sweetvetch herb, 0.1-1% of Chinese date root bark, 1-3% of Japanese creeper, 0.4-1% of grape vine, 1-4% of pearl, 2-4% of borneol, 0.1-1% of borax, 2-8% of angelica sinensis, 0.2-0.8% of elephant hide, 2-6% of cinnabar, 2-3% of astragalus membranaceus, 2-3% of angelica dahurica, 1-3% of ceramide, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate, 0.4-1% of Chinese pulsatilla root extract and 2-5% of sophora flavescens powder.
Further, the components and weight of the formula of the rejuvenation liquid comprise 25% of lanolin oil, 20% of olive oil, 12% of almond oil, 1% of rehmannia root, 0.5% of dwarf lilyturf tuber, 0.5% of radix stemonae, 1% of Chinese violet, 2% of gardenia, 3% of poria cocos, 0.4% of honeysuckle, 0.6% of palmate giraldii herb, 2% of corydalis saxicola, 3% of golden flower, 0.6% of field thistle herb, 0.4% of rabdosia lophanthistle, 0.5% of Chinese knotweed herb, 2% of pteris vittata, 1% of cortex populi, 1% of ampelopsis grossedentata, 3% of pearl, 2% of borneol, 1% of borax, 2% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of astragalus root, 3% of angelica dahurica, 1% of ceramide, 2% of purslane extract, 0.3%.
Further, the components and weight of the formula of the rejuvenation liquid comprise 22% of lanolin oil, 24% of olive oil, 11% of almond oil, 2% of rehmannia root, 0.3% of dwarf lilyturf tuber, 0.7% of radix stemonae, 1% of Chinese violet, 2% of gardenia, 1% of poria cocos, 0.4% of honeysuckle, 0.6% of radix palmettiae, 2% of corydalis saxicola, 3% of golden flower, 0.6% of field thistle, 0.4% of rabdosia lophanthistle, 0.5% of Chinese knotweed herb, 3% of fern rhizome, 0.5% of pig bristlegrass, 0.2% of buddleja, 0.8% of cortex ziziphi spinosae, 1% of Japanese creeper, 0.6% of snake grape, 1% of pearl, 3% of borneol, 0.4% of borax, 4% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of radix astragali, 3% of radix angelicae.
Further, the components and weight of the formula of the rejuvenation liquid comprise, by weight, 12% of lanolin oil, 7% of olive oil, 10% of almond oil, 2% of rehmannia root, 2% of dwarf lilyturf tuber, 1% of vine stemona root, 1% of Chinese violet, 2% of cape jasmine fruit, 3% of poria cocos, 0.4% of honeysuckle, 0.6% of palmate giraldii herb, 2% of corydalis saxicola, 3% of datura flower, 1% of field thistle herb, 1% of linearstripe rabdosia herb, 1% of Chinese knotweed herb, 8% of fern rhizome, 0.8% of bristlegrass, 0.2% of buddleia leia, 1% of cortex zizyphi spinosae, 3% of Japanese poplar, 0.4% of ampelopsis grossedentata, 4% of pearl, 4% of borneol, 0.6% of borax, 6% of angelica sinensis, 0.2% of elephant skin, 5% of cinnabar, 3%.
A preparation method of a rejuvenation liquid for treating burns and scalds comprises the following steps:
(1) 1 to 2 percent of rehmannia root, 0.5 to 4 percent of dwarf lilyturf tuber, 0.4 to 1 percent of radix stemonae, 0.1 to 1 percent of Chinese violet, 1 to 2 percent of gardenia, 1 to 3 percent of tuckahoe, 0.4 to 1 percent of stephania sinica, 0.6 to 2 percent of large sesame, 1 to 2 percent of corydalis saxicola, 1 to 3 percent of golden leaf, 0.6 to 1 percent of Indian kalimeris herb, 0.4 to 1 percent of rabdosia lophanthide, 0.5 to 1 percent of Chinese knotweed herb, 2 to 8 percent of fern rhizome, 0.5 to 1 percent of Chinese bristlegrass, 0.1 to 1 percent of buddleia, 0.1 to 1 percent of wild jujube root bark, 1 to 3 percent of Japanese borer, 0.4 to 1 percent of snake grape, 1 to 4 percent of pearl, 2 to 4 percent of borneol, 0.1 to 1 percent of borax, 2 to 8 percent of angelica, 0.2 to 0, 2-3% of angelica dahurica, 1-3% of ceramide and 2-5% of sophora flavescens powder are accurately weighed according to a certain proportion, the raw materials are respectively prepared into fine powder of 120 meshes, then the fine powder of all the raw materials is stirred and mixed to obtain a mixture A, the mixture A is sterilized, the stirring and mixing time is 10-20min, the stirring temperature range is 30-40 ℃, the sterilization is microwave sterilization, the microwave sterilization temperature is 80-90 ℃, and the microwave sterilization time is 3-5 min;
(2) accurately weighing 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract into the mixture A, uniformly stirring, wherein the stirring and mixing time is 20-30min, and the stirring temperature is in the range of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
Further, when the ionic water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B, the mixture is firstly put into an emulsifying pot, stirred and heated to 80-85 ℃, and the temperature is kept for 20 minutes.
Further, the antioxidant is p-hydroxyacetophenone, the anti-allergy agent is allantoin, and the emulsifier is cetearyl glucoside.
Further, the emollient is at least one of polydimethylsiloxane, caprylic/capric triglyceride, petrolatum, and jojoba seed oil.
Further, the thickening agent is at least one of xanthan gum and sodium acrylate/sodium acryloyldimethyl taurate copolymer.
Further, the coemulsifier is cetearyl alcohol and sodium stearyl glutamate.
The invention has the beneficial effects that:
(1) the skin rejuvenation and skin rejuvenation lotion is externally applied to burn wounds, forms a layer of protective film immediately, has the effects of resisting and inhibiting bacteria, removing slough and promoting granulation, can quickly liquefy and separate necrotic crust or eschar of burn, avoids the occurrence of burn wound sepsis, can promote granulation growth and make the crust thereof fast when the skin rejuvenation lotion treats deep burn, does not need skin grafting, can inhibit the formation of myofibroblasts, can prevent the generation of scars, has unique effect on treating facial burn and scald, can heal the facial burn and scald within 48 hours generally, and has no difference with normal skin after treatment;
(2) the invention can effectively prevent burn infection, relieve pain of the burn wound, promote early healing of the wound, prevent scar hyperplasia and pruritus, has obvious pain relieving effect and anti-infection effect, effectively accelerates the healing of the wound, solves the problem that no scar is left in the burn and scald, has good pain relieving effect on the burn and scald wound, has strong infection preventing and anti-infection capacity, has no local anaphylactic reaction and toxic and side effect, does not scab, does not deepen the wound, can promote the growth of epithelium and granulation tissues for the burn and scald, and does not need skin grafting;
(3) the invention has the advantages of simple preparation process, uniform gauze adhesion, low cost, convenient application, short treatment period, quick curative effect, special effect on large-area infectious wound and wound at joints of four limbs, wide social benefit, simple preparation, good absorption effect, long duration of the medicinal effect, obvious curative effect, no side effect, high safety, low production cost, contribution to timely alleviating symptoms of patients and high practical value and popularization value, and is suitable for hospitals and families at all levels.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments that can be derived by one of ordinary skill in the art from the embodiments given herein are intended to be within the scope of the present invention.
According to an embodiment of the present invention, there is provided a rejuvenation liquid for treating burns and scalds.
According to the embodiment of the invention, the formula of the rejuvenation liquid for treating burns and scalds comprises, by weight, 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-2% of rehmannia, 0.5-4% of radix ophiopogonis, 0.4-1% of radix stemonae, 0.1-1% of herba violae, 1-2% of cape jasmine, 1-3% of poria cocos, 0.4-1% of herba silverweed, 0.6-2% of palmate giraldii herb, 1-2% of corydalis saxicola, 1-3% of datura flower grass, 0.6-1% of field thistle, 0.4-1% of herba rabdosiae lophanthistle, 0.5-1% of Chinese knotweed herb, 2-8% of pteris latifolia thumb, 0.1-1% of buddleja, 0.1-1% of cortex ziziphi spinosae and 1-3% of populus davidiana, 0.4-1% of ampelopsis, 1-4% of pearl, 2-4% of borneol, 0.1-1% of borax, 2-8% of angelica, 0.2-0.8% of elephant hide, 2-6% of cinnabar, 2-3% of astragalus root, 2-3% of angelica dahurica, 1-3% of ceramide, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate, 0.4-1% of pulsatilla extract and 2-5% of sophora flavescens powder.
The pharmacological activity of part of the traditional Chinese medicine raw materials of the invention is as follows:
radix Stephaniae Sinicae is used for preventing root and stem of Verticillium dahliae Freyn of Laurencia, bitter and cold, and has effects of clearing heat and detoxicating; promoting urination and treating stranguria; removing blood stasis and relieving pain. Mainly treating wind-heat type common cold; sore throat; toothache; stomach pain; abdominal pain; dysentery due to damp-heat; malaria; pain in urination; traumatic injury and pain; sprain and contusion.
Palmate girardinia herb, which is the whole herb or root of girardinia palmata of the Urticaceae family, has the effects of dispelling pathogenic wind, relieving exterior syndrome, benefiting qi, eliminating phlegm, clearing away heat and toxic materials. Can be used for treating cough due to wind injury, chest distress, excessive phlegm, skin pruritus, and skin sore.
Corydalis saxicola bunting, which is root of corydalis saxicola bunting of Papaveraceae, is bitter, cool, enters stomach and large intestine channels, and has effects of clearing heat and detoxicating; induce diuresis to alleviate pain and stop bleeding. Major hepatitis; erosion of the mouth and tongue; a fire hole; nebula; dysentery; diarrhea; abdominal pain; haemorrhoids bleeding.
The large leaf golden flower herb is the whole grass or rhizome of the Stenoloma chusanum (Linn.) Ching of the family Leptospermaceae, is slightly bitter and cold, enters liver, lung and large intestine channels, and clears away heat and toxic materials; removing dampness; stopping bleeding. Mainly treating cold and fever; cough; swollen and sore throat; enteritis; dysentery; hepatitis; damp-heat leucorrhea; carbuncle sore and pyogenic infections; mumps; aphtha; scald and burn; bite of poisonous snake and rabies; eczema of the skin; hematemesis; hematuria; hematochezia; bleeding due to trauma.
Herba Cardui Crispi, which is herb or root of herba Cardui Crispi of Compositae, has slightly bitter taste and cold property, and has effects of dispelling pathogenic wind, clearing heat, promoting diuresis, cooling blood and removing blood stasis. It can be used for treating wind-heat type common cold, dizziness, wind-heat type arthralgia, skin pruritus, urinary tract infection, chyluria, hematuria, leukorrhagia, traumatic injury, blood stasis, furuncle, toxic swelling, and burn. Common Tibet Chinese herbal medicine: blood cooling, stopping bleeding, removing blood stasis and relieving swelling. It can be used for treating hemorrhage, traumatic injury, blood stasis, swelling, skin ulcer, burn, and scald.
Rabdosia lophanthide (Rabdosia lophanthide) Hara, a whole herb of Rabdosia lophanthide (Lamiaceae), is bitter in taste, cold in nature, enters liver, gallbladder and large intestine channels, and clears away heat and toxic materials; removing dampness and eliminating jaundice; dispel stasis and relieve swelling. Damp-heat-dominant jaundice; cholecystitis (cholecystitis); diarrhea; sores and swelling; traumatic injury and pain.
The herb of Chinese knotweed is the whole herb of Chinese knotweed of Polygonaceae, and is pungent, bitter, cool in nature, and capable of clearing heat and promoting diuresis; cooling blood and removing toxic substance; calming the liver and improving eyesight; promoting blood circulation and relaxing muscles and tendons. Major dysentery; diarrhea; swollen and sore throat; diphtheria; cough due to lung heat; (ii) pertussis; hepatitis; leucorrhea; cancer and swelling; otitis media; eczema; vertigo and tinnitus; corneal clouding; traumatic injury.
Fern root, rhizome of fern of Pteridaceae, sweet and cold, enters lung, liver, spleen and large intestine channels, and clears heat; removing dampness; calming the liver and soothing the nerves; detoxify and detumescence. Main heating; swollen and sore throat; diarrhea; dysentery; jaundice; leucorrhea; hypertension; dizziness and insomnia; rheumatic arthralgia; hemorrhoids; rectocele; eczema; scalding; bite by snake and insect.
Herba Adianti, is the whole plant of Adiantum capillus-veneris and Adiantum brevifilis of Adiantaceae, bitter, cool, enters liver and kidney channels, and has effects of clearing away heat and toxic materials; induce diuresis to treat stranguria. Mainly treating cold and fever; cough due to lung heat; diarrhea due to damp-heat; dysentery; drenching turbid liquor; leucorrhea; acute mastitis; scrofula; furunculosis; scalding; bite by poisonous snake. Quanzhou materia Medica: dispelling arthralgia, expelling wind, promoting blood circulation, removing toxic substances, removing blood stasis, promoting tissue regeneration, softening hard masses, removing food retention, and relieving pain. It is indicated for all arthralgia, soreness and pain of waist and bone, traumatic injury.
The buddleia is the whole plant of buddleia of Loganiaceae, is slightly pungent, bitter and warm, and has the effects of dispelling pathogenic wind, removing dampness, relieving cough, eliminating phlegm, removing blood stasis and killing parasites. Bronchitis, cough, asthma, rheumatoid arthritis, traumatic injury; is externally used for treating traumatic hemorrhage, burn and scald,
cortex Choerospondiatis root bark, root bark of Rhamnaceae plant cortex Choerospondiatis, astringent, warm, kidney meridian entered, and hemostatic; astringing essence; astringe dampness and heal wound. Governing hematochezia; (ii) metrorrhagia and metrostaxis; smoothing sperm; leucorrhea; burn and scald.
Ramulus et folium Bauhiniae Bicoloris is bark of ramulus et folium Bauhiniae Bicoloris of Salicaceae, bitter and cold in nature, and has effects in cooling blood and removing toxic substance; dispelling wind and eliminating dampness. Treating common cold; hepatitis; dysentery; rheumatic pain; edema of the foot; burns and scalds; scabies, tinea pedis and sore.
Ampelopsis brevipedunculata (stem and leaf of Ampelopsis brevipedunculata (L.) hand. -Mazz. of Vitaceae), has effects of pungent taste, bitter taste, cooling, clearing away heat and toxic materials, dispelling pathogenic wind, activating collaterals, relieving pain, and stopping bleeding. Can be used for treating rheumatic arthritis, emesis, diarrhea, and ulcer; it is used externally to treat traumatic injury, swelling and pain, sore, ulcer, traumatic hemorrhage, burn and scald.
Further, the components and weight of the formula of the rejuvenation liquid comprise 25% of lanolin oil, 20% of olive oil, 12% of almond oil, 1% of rehmannia root, 0.5% of dwarf lilyturf tuber, 0.5% of radix stemonae, 1% of Chinese violet, 2% of gardenia, 3% of poria cocos, 0.4% of honeysuckle, 0.6% of palmate giraldii herb, 2% of corydalis saxicola, 3% of golden flower, 0.6% of field thistle herb, 0.4% of rabdosia lophanthistle, 0.5% of Chinese knotweed herb, 2% of pteris vittata, 1% of cortex populi, 1% of ampelopsis grossedentata, 3% of pearl, 2% of borneol, 1% of borax, 2% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of astragalus root, 3% of angelica dahurica, 1% of ceramide, 2% of purslane extract, 0.3%.
Further, the components and weight of the formula of the rejuvenation liquid comprise 22% of lanolin oil, 24% of olive oil, 11% of almond oil, 2% of rehmannia root, 0.3% of dwarf lilyturf tuber, 0.7% of radix stemonae, 1% of Chinese violet, 2% of gardenia, 1% of poria cocos, 0.4% of honeysuckle, 0.6% of radix palmettiae, 2% of corydalis saxicola, 3% of golden flower, 0.6% of field thistle, 0.4% of rabdosia lophanthistle, 0.5% of Chinese knotweed herb, 3% of fern rhizome, 0.5% of pig bristlegrass, 0.2% of buddleja, 0.8% of cortex ziziphi spinosae, 1% of Japanese creeper, 0.6% of snake grape, 1% of pearl, 3% of borneol, 0.4% of borax, 4% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of radix astragali, 3% of radix angelicae.
Further, the components and weight of the formula of the rejuvenation liquid comprise, by weight, 12% of lanolin oil, 7% of olive oil, 10% of almond oil, 2% of rehmannia root, 2% of dwarf lilyturf tuber, 1% of vine stemona root, 1% of Chinese violet, 2% of cape jasmine fruit, 3% of poria cocos, 0.4% of honeysuckle, 0.6% of palmate giraldii herb, 2% of corydalis saxicola, 3% of datura flower, 1% of field thistle herb, 1% of linearstripe rabdosia herb, 1% of Chinese knotweed herb, 8% of fern rhizome, 0.8% of bristlegrass, 0.2% of buddleia leia, 1% of cortex zizyphi spinosae, 3% of Japanese poplar, 0.4% of ampelopsis grossedentata, 4% of pearl, 4% of borneol, 0.6% of borax, 6% of angelica sinensis, 0.2% of elephant skin, 5% of cinnabar, 3%.
A preparation method of a rejuvenation liquid for treating burns and scalds comprises the following steps:
(1) 1 to 2 percent of rehmannia root, 0.5 to 4 percent of dwarf lilyturf tuber, 0.4 to 1 percent of radix stemonae, 0.1 to 1 percent of Chinese violet, 1 to 2 percent of gardenia, 1 to 3 percent of tuckahoe, 0.4 to 1 percent of stephania sinica, 0.6 to 2 percent of large sesame, 1 to 2 percent of corydalis saxicola, 1 to 3 percent of golden leaf, 0.6 to 1 percent of Indian kalimeris herb, 0.4 to 1 percent of rabdosia lophanthide, 0.5 to 1 percent of Chinese knotweed herb, 2 to 8 percent of fern rhizome, 0.5 to 1 percent of Chinese bristlegrass, 0.1 to 1 percent of buddleia, 0.1 to 1 percent of wild jujube root bark, 1 to 3 percent of Japanese borer, 0.4 to 1 percent of snake grape, 1 to 4 percent of pearl, 2 to 4 percent of borneol, 0.1 to 1 percent of borax, 2 to 8 percent of angelica, 0.2 to 0, 2-3% of angelica dahurica, 1-3% of ceramide, 1-4% of purslane extract, 0.1-3% of ammonium acryloyldimethyl taurate, 0.4-1% of Chinese pulsatilla root extract and 2-5% of sophora flavescens powder are accurately weighed according to a certain proportion, the raw materials are respectively prepared into fine powder of 120 meshes, then the fine powder of all the raw materials is stirred and mixed to obtain a mixture A, the mixture A is sterilized, the stirring and mixing time is 10-20min, the stirring temperature is between 30 ℃ and 40 ℃, the sterilization is microwave sterilization, the microwave sterilization temperature is 80-90 ℃, and the microwave sterilization time is 3-5 min;
(2) accurately weighing 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract into the mixture A, uniformly stirring, wherein the stirring and mixing time is 20-30min, and the stirring temperature is in the range of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
Further, when the ionic water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B, the mixture is firstly put into an emulsifying pot, stirred and heated to 80-85 ℃, and the temperature is kept for 20 minutes.
Further, the antioxidant is p-hydroxyacetophenone, the anti-allergy agent is allantoin, and the emulsifier is cetearyl glucoside.
Further, the emollient is at least one of polydimethylsiloxane, caprylic/capric triglyceride, petrolatum, and jojoba seed oil.
Further, the thickening agent is at least one of xanthan gum and sodium acrylate/sodium acryloyldimethyl taurate copolymer.
Further, the coemulsifier is cetearyl alcohol and sodium stearyl glutamate.
Example one
The invention provides a technical scheme of a skin rejuvenation liquid for treating burns and scalds, which comprises the following steps: the components and weight percentage of the formula of the rejuvenation liquid for rejuvenating the skin comprise 25% of lanolin oil, 20% of olive oil, 12% of almond oil, 1% of rehmannia root, 0.5% of dwarf lilyturf tuber, 0.5% of vine stemona root, 1% of Chinese violet, 2% of gardenia, 3% of poria cocos, 0.4% of Japanese stephania root, 0.6% of palmate giraldii herb, 2% of corydalis saxicola, 3% of large leaf golden flower herb, 0.6% of field thistle herb, 0.4% of rabdosia lophanthistle, 0.5% of Chinese knotweed herb, 2% of fern rhizome, 0.5% of pig bristlegrass, 1% of buddleja's japonicas root bark, 1% of Chinese wild jujube root bark, 1% of Japanese creeper, 1% of pearl, 2% of borneol, 1% of borax, 2% of Chinese angelica, 0.2% of elephant skin, 2% of.
The preparation method of the rejuvenation solution for treating burns and scalds comprises the following steps:
(1) 1% of rehmannia root, 0.5% of dwarf lilyturf tuber, 0.5% of vine stemona root, 1% of Chinese violet, 2% of gardenia, 3% of poria cocos, 0.4% of silverweed, 0.6% of large sesame, 2% of corydalis saxicola, 3% of golden flower bud, 0.6% of Chinese feverfew, 0.4% of rabdosia lophanthide, 0.5% of Chinese knotweed, 0.5% of fern rhizome, 0.5% of pig bristlegrass, 1% of buddleia, 1% of cortex zizyphi spinosae, 1% of Japanese creeper, 1% of snake grape, 3% of pearl, 2% of borneol, 1% of borax, 2% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of astragalus root, 3% of angelica dahurica, 1% of ceramide, 2% of purslane extract, 0.3% of ammonium acryloyldimethyltaurate, 0.5% of pulsatilla extract and 2% of sophora, stirring and mixing for 10-20min at 30-40 deg.C, and sterilizing by microwave at 80-90 deg.C for 3-5 min;
(2) accurately weighing 25% of lanolin oil, 20% of olive oil, 12% of almond oil, 2% of purslane extract, 0.3% of acryloyl dimethyl ammonium taurate and 0.5% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 25% of lanolin oil, 20% of olive oil, 12% of almond oil, 2% of purslane extract, 0.3% of acryloyl dimethyl ammonium taurate and 0.5% of Chinese pulsatilla root extract into the mixture A, uniformly stirring, wherein the stirring and mixing time is 20-30min, and the stirring temperature is in the range of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C; when the ionized water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B, the mixture is stirred and heated to 80-85 ℃ in an emulsifying pot, and the temperature is kept for 20 minutes; the antioxidant is p-hydroxyacetophenone, the anti-allergic agent is allantoin, the emulsifier is cetearyl glucoside, the emollient is a mixture of polydimethylsiloxane and jojoba seed oil, the thickener is a mixture of xanthan gum and sodium acrylate, and the co-emulsifier is cetearyl alcohol and sodium stearyl glutamate;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
Example two
The invention provides a technical scheme of a skin rejuvenation liquid for treating burns and scalds, which comprises the following steps: the components and weight percentage of the formula of the rejuvenation liquid for rejuvenating skin comprise 2% of rehmannia, 0.3% of radix ophiopogonis, 0.7% of radix stemonae, 1% of Chinese violet, 2% of cape jasmine, 1% of poria cocos, 0.4% of silverweed, 0.6% of palmate, 2% of corydalis saxicola, 3% of golden camellia, 0.6% of field ardisia, 0.4% of herba rabdosiae lophanthide, 0.5% of herb of common knotweed, 3% of fern rhizome, 0.5% of pig bristlegrass, 0.2% of buddleia, 0.8% of cortex ziziphi spinosae, 1% of Japanese raisin, 1% of pearl, 3% of borneol, 0.4% of borax, 4% of angelica sinensis, 0.2% of elephant skin, 2% of cinnabar, 2%.
The preparation method of the rejuvenation solution for treating burns and scalds comprises the following steps:
(1) accurately weighing 2% of rehmannia, 0.3% of radix ophiopogonis, 0.7% of radix stemonae, 1% of philippine violet herb, 2% of cape jasmine fruit, 1% of poria cocos, 0.4% of herba silverweed, 0.6% of rhizoma palmettiae, 2% of corydalis, 3% of golden flower, 0.6% of Chinese feverfew, 0.4% of linearstripe rabdosia herb, 0.5% of herb of Chinese knotweed, 3% of fern rhizome, 0.5% of herba hedyotis, 0.2% of buddlei, 0.2% of buddleia, 0.8% of cortex zizyphi spinosae, 1% of Chinese littleleaf box tree, 0.6% of snake grape, 1% of pearl, 3% of borneol, 0.4% of borax, 4% of Chinese angelica, 0.2% of elephant hide, 2% of cinnabar, 2% of radix astragali, 3% of angelica dahurica, 3% of ceramide and 2% of sophora flavescens powder according to a certain proportion, respectively making fine powder into, the sterilization is microwave sterilization, wherein the microwave sterilization temperature is 80-90 ℃, and the microwave sterilization time is 3-5 min;
(2) accurately weighing 22% of lanolin oil, 24% of olive oil, 11% of almond oil, 1% of purslane extract, 0.3% of acryloyl dimethyl ammonium taurate and 0.5% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 22% of lanolin oil, 24% of olive oil, 11% of almond oil, 1% of purslane extract, 0.3% of acryloyl dimethyl ammonium taurate and 0.5% of Chinese pulsatilla root extract into the mixture A, and uniformly stirring for 20-30min at the stirring temperature of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C; when the ionized water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B, the mixture is stirred and heated to 80-85 ℃ in an emulsifying pot, and the temperature is kept for 20 minutes; the antioxidant is p-hydroxyacetophenone, the anti-allergic agent is allantoin, the emulsifier is cetearyl glucoside, the emollient is polydimethylsiloxane, the thickener is a sodium acrylate/sodium acryloyldimethyl taurate copolymer, and the co-emulsifier is cetearyl alcohol and sodium stearyl glutamate;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
EXAMPLE III
The invention provides a technical scheme of a skin rejuvenation liquid for treating burns and scalds, which comprises the following steps: the components and weight of the formula of the rejuvenation liquid for rejuvenating skin comprise 2% of rehmannia, 2% of radix ophiopogonis, 1% of radix stemonae, 1% of herba violae, 2% of fructus gardeniae, 3% of poria cocos, 0.4% of radix cynanchi wilfordii, 0.6% of rhizoma palmettiae, 2% of corydalis saxicola, 3% of golden flower, 1% of herba swiftlet, 1% of herba rabdosiae lophanthi, 1% of herb of Chinese knotweed, 8% of fern rhizome, 0.8% of herba hedyotis diffusae, 0.2% of buddleia, 1% of cortex ziziphi spinosae, 3% of Japanese creeper bark, 0.4% of snake grape, 4% of pearl, 4% of borneol, 0.6% of borax, 6% of angelica sinensis, 0..
The preparation method of the rejuvenation solution for treating burns and scalds comprises the following steps:
(1) 2 percent of rehmannia root, 2 percent of dwarf lilyturf tuber, 1 percent of radix stemonae, 1 percent of Chinese violet, 2 percent of gardenia, 3 percent of tuckahoe, 0.4 percent of stephania sinica, 0.6 percent of rhizoma drynariae, 2 percent of corydalis saxicola, 3 percent of golden flower herb, 1 percent of field thistle, 1 percent of rabdosia lophanthide, 1 percent of Chinese knotweed herb, 8 percent of fern rhizome, 0.8 percent of pig bristlegrass, 0.2 percent of buddleia, 1 percent of cortex zizyphi spinosae, 3 percent of Japanese creeper root bark, 0.4 percent of snake grape, 4 percent of pearl, 4 percent of borneol, 0.6 percent of borax, 6 percent of angelica, 0.2 percent of elephant skin, 5 percent of cinnabar, 3 percent of radix angelicae, 3 percent of ceramide and 4 percent of radix sophorae flavescentis powder are accurately weighed according to a certain proportion and respectively prepared into fine powder of 120 meshes, then all the fine powder of, the sterilization is microwave sterilization, wherein the microwave sterilization temperature is 80-90 ℃, and the microwave sterilization time is 3-5 min;
(2) accurately weighing 12% of lanolin oil, 7% of olive oil, 10% of almond oil, 4% of purslane extract, 0.2% of acryloyl dimethyl ammonium taurate and 0.6% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 12% of lanolin oil, 7% of olive oil, 10% of almond oil, 4% of purslane extract, 0.2% of acryloyl dimethyl ammonium taurate and 0.6% of Chinese pulsatilla root extract into the mixture A, uniformly stirring, wherein the stirring and mixing time is 20-30min, and the stirring temperature is in the range of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C; when the ionized water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B, the mixture is stirred and heated to 80-85 ℃ in an emulsifying pot, and the temperature is kept for 20 minutes; the antioxidant is p-hydroxyacetophenone, the anti-allergic agent is allantoin, the emulsifier is cetearyl glucoside, the emollient is a mixture of polydimethylsiloxane and caprylic/capric triglyceride, the thickener is sodium acrylate/sodium acryloyldimethyl taurate copolymer, and the co-emulsifier is cetearyl alcohol and sodium stearyl glutamate;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
The skin rejuvenation and skin rejuvenation lotion is externally applied to burn wounds, forms a layer of protective film immediately, has the effects of resisting and inhibiting bacteria, removing slough and promoting granulation, can quickly liquefy and separate necrotic crust or eschar of burn, avoids the occurrence of burn wound sepsis, can promote granulation growth and make the crust thereof fast when the skin rejuvenation lotion treats deep burn, does not need skin grafting, can inhibit the formation of myofibroblasts, can prevent the generation of scars, has unique effect on treating facial burn and scald, can heal the facial burn and scald within 48 hours generally, and has no difference with normal skin after treatment; the Chinese medicinal composition can effectively prevent burn infection, relieve pain of the burn wound, promote early healing of the wound, prevent scar hyperplasia and pruritus, has obvious pain relieving effect and anti-infection effect, effectively accelerates the healing of the wound, solves the problem that no scar is left in the burn and scald, has good pain relieving effect on the burn and scald wound, prevents infection and has strong anti-infection force, has no local anaphylactic reaction and toxic or side effect, does not scab, does not deepen the wound, can promote the growth of epithelial tissues and granulation tissues in the burn and scald, and does not need skin grafting; the gauze has the advantages of simple preparation process, uniform adhesion of the gauze, low cost, convenient application, short treatment period, quick curative effect, special effect on large-area infectious wound surfaces and wound surfaces of joints of four limbs, suitability for hospitals and families at all levels, wide social benefit, simple preparation, good absorption effect, long duration of the medicinal effect, remarkable curative effect, no side effect, high safety, low production cost, contribution to timely alleviating symptoms of patients and very high practical value and popularization value.
In the present invention, unless otherwise expressly specified or limited, the terms "mounted," "disposed," "connected," "secured," "screwed" and the like are to be construed broadly, e.g., as meaning fixedly connected, detachably connected, or integrally formed; can be mechanically or electrically connected; the terms may be directly connected or indirectly connected through an intermediate, and may be communication between two elements or interaction relationship between two elements, unless otherwise specifically limited, and the specific meaning of the terms in the present invention will be understood by those skilled in the art according to specific situations.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. The skin rejuvenation liquid for treating burns and scalds is characterized by comprising, by weight, 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-2% of rehmannia, 0.5-4% of radix ophiopogonis, 0.4-1% of radix stemonae, 0.1-1% of Chinese violet, 1-2% of cape jasmine, 1-3% of poria cocos, 0.4-1% of stephania sinica, 0.6-2% of palmate giraldii, 1-2% of corydalis saxicola, 1-3% of golden leaf, 0.6-1% of field thistle herb, 0.4-1% of lineare herb, 0.5-1% of Chinese knotweed herb, 2-8% of fern rhizome, 0.5-1% of bristlegrass, 0.1-1% of buddleja, 0.1-1% of Chinese date root bark, and 1-3% of Chinese populus, 0.4-1% of ampelopsis, 1-4% of pearl, 2-4% of borneol, 0.1-1% of borax, 2-8% of angelica, 0.2-0.8% of elephant hide, 2-6% of cinnabar, 2-3% of astragalus root, 2-3% of angelica dahurica, 1-3% of ceramide, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate, 0.4-1% of pulsatilla extract and 2-5% of sophora flavescens powder.
2. The rejuvenating liquid for treating burns and scalds according to claim 1, wherein the formulation comprises, by weight, 25% lanolin oil, 20% olive oil, 12% almond oil, 1% rehmannia, 0.5% ophiopogon root, 0.5% stemona, 1% Chinese violet, 2% gardenia, 3% poria, 0.4% irkutsk, 0.6% palmate, 2% corydalis, 3% datura flower, 0.6% garden balsam, 0.4% serrate rabdosia herb, 0.5% herb, 2% Chinese knotweed, 2% fern root, 0.5% pig bristlegrass, 1% buddleia, 1% zizyphus jujube root bark, 1% ampelopsis japonica, 3% pearl, 2% borneol, 1% borax, 2% angelica, 0.2% elephant skin, 2% astragalus root, 3% angelica dahurica, 1% ceramide, 2% purslane, 0.3% ammonium acryloyldimethyl sulfonate, 0.5 percent of Chinese pulsatilla root extract and 2 percent of sophora flavescens powder.
3. The rejuvenating liquid for treating burns and scalds according to claim 1, wherein the formulation comprises, by weight, 22% lanolin oil, 24% olive oil, 11% almond oil, 2% rehmannia, 0.3% ophiopogon root, 0.7% stemona, 1% viola philippica, 2% gardenia, 1% poria cocos, 0.4% stephania, 0.6% palmate, 2% corydalis saxicola, 3% datura flower, 0.6% philippine flemingia root, 0.4% serrate rabdosia herb, 0.5% leonurus, 0.5% pig bristlegrass, 0.2% buddleia, 0.8% choerospondias radices cortex, 1% buergeriana, 0.6% grape vine, 1% borneol 3%, 0.4% borax, 4% angelica sinensis, 0.2% elephant hide, 2% cinnabar, 3% astragalus root, 3% ceramide, 1% purslane extract, 0.3% ammonium dimethyl sulfonate, 0.5 percent of Chinese pulsatilla root extract and 2 percent of sophora flavescens powder.
4. The rejuvenating liquid for treating burns and scalds according to claim 1, wherein the formulation comprises, by weight, 12% lanolin oil, 7% olive oil, 10% almond oil, 2% rehmannia, 2% ophiopogon root, 1% stemona japonica, 1% viola philippica, 2% gardenia, 3% poria, 0.4% stephania, 0.6% palmate giraldii, 2% corydalis saxicola, 3% datura flower, 1% smallflower thistle, 1% serrate rabdosia herb, 1% herb of Chinese knotweed, 8% fern rhizome, 0.8% pig bristlegrass, 0.2% buddleja, 1% choerospondias root bark, 3% cottonwood, 0.4% snake grape, 4% pearl, 4% borneol, 0.6% borax, 6% angelica, 0.2% elephant skin, 5% astragalus root, 3% angelica dahurica, 3% ceramide, 4% extract, 0.2% ammonium acryloyldimethyl taurate, 0.6 percent of Chinese pulsatilla root extract and 4 percent of sophora flavescens powder.
5. The method for preparing the rejuvenation liquid for treating burns and scalds according to any one of claims 1 to 4, wherein the rejuvenation liquid comprises the following steps:
(1) 1 to 2 percent of rehmannia root, 0.5 to 4 percent of dwarf lilyturf tuber, 0.4 to 1 percent of radix stemonae, 0.1 to 1 percent of Chinese violet, 1 to 2 percent of gardenia, 1 to 3 percent of tuckahoe, 0.4 to 1 percent of stephania sinica, 0.6 to 2 percent of large sesame, 1 to 2 percent of corydalis saxicola, 1 to 3 percent of golden leaf, 0.6 to 1 percent of Indian kalimeris herb, 0.4 to 1 percent of rabdosia lophanthide, 0.5 to 1 percent of Chinese knotweed herb, 2 to 8 percent of fern rhizome, 0.5 to 1 percent of Chinese bristlegrass, 0.1 to 1 percent of buddleia, 0.1 to 1 percent of wild jujube root bark, 1 to 3 percent of Japanese borer, 0.4 to 1 percent of snake grape, 1 to 4 percent of pearl, 2 to 4 percent of borneol, 0.1 to 1 percent of borax, 2 to 8 percent of angelica, 0.2 to 0, 2-3% of angelica dahurica, 1-3% of ceramide and 2-5% of sophora flavescens powder are accurately weighed according to a certain proportion, the raw materials are respectively prepared into fine powder of 120 meshes, then the fine powder of all the raw materials is stirred and mixed to obtain a mixture A, the mixture A is sterilized, the stirring and mixing time is 10-20min, the stirring temperature range is 30-40 ℃, the sterilization is microwave sterilization, the microwave sterilization temperature is 80-90 ℃, and the microwave sterilization time is 3-5 min;
(2) accurately weighing 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of ammonium acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract according to a certain proportion, sequentially adding 10-30% of lanolin oil, 6-24% of olive oil, 4-12% of almond oil, 1-4% of purslane extract, 0.1-3% of acryloyl dimethyl taurate and 0.4-1% of Chinese pulsatilla root extract into the mixture A, uniformly stirring, wherein the stirring and mixing time is 20-30min, and the stirring temperature is in the range of 40-60 ℃; obtaining a mixture B;
(3) sequentially adding ionized water, humectant, emulsifier, co-emulsifier, emollient, thickener, emulsifier, and anti-allergy agent into the mixture B, stirring for 30-60min at 80-85 deg.C, homogenizing, emulsifying, holding the temperature for 30min, and cooling to 45 deg.C under stirring to obtain mixture C;
(4) adding allantoin into the mixture C, mixing and dissolving, stirring uniformly, adding part of skin conditioner and pH regulator, stirring uniformly, homogenizing, and cooling to 45 deg.C to obtain mixture D;
(5) stirring and mixing the mixture A and the mixture D for 40-60min at the stirring temperature of 60-80 ℃, cooling to 40-45 ℃, and discharging for later use;
(6) after being placed for 24 hours, the mixture is filled and stored after being checked to be qualified.
6. The preparation method of the skin rejuvenation liquid for treating burns and scalds according to claim 5, wherein the ionic water, the humectant, the emulsifier, the co-emulsifier, the emollient, the thickener, the emulsifier and the anti-allergy agent are stirred and mixed with the mixture B in an emulsifying pot, the temperature is raised to 80-85 ℃ by stirring, and the temperature is maintained for 20 minutes.
7. The method for preparing the rejuvenation liquid for treating burns and scalds according to claim 5, wherein the antioxidant is p-hydroxyacetophenone, the anti-allergic agent is allantoin, and the emulsifier is cetearyl glucoside.
8. The preparation method of the skin rejuvenation liquid for treating burns and scalds according to claim 5, wherein the emollient is at least one of polydimethylsiloxane, caprylic/capric triglyceride, petrolatum, jojoba seed oil.
9. The method of preparing a skin rejuvenation solution for the treatment of burn and scald as claimed in claim 5, wherein said thickening agent is at least one of xanthan gum and sodium acrylate/sodium acryloyldimethyl taurate copolymer.
10. The preparation method of the rejuvenating liquid for treating burns and scalds according to claim 5, wherein the co-emulsifier is cetearyl alcohol and sodium stearyl glutamate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011328397.9A CN112843193A (en) | 2020-11-24 | 2020-11-24 | Skin rejuvenation liquid for treating burns and scalds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011328397.9A CN112843193A (en) | 2020-11-24 | 2020-11-24 | Skin rejuvenation liquid for treating burns and scalds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112843193A true CN112843193A (en) | 2021-05-28 |
Family
ID=75996399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011328397.9A Pending CN112843193A (en) | 2020-11-24 | 2020-11-24 | Skin rejuvenation liquid for treating burns and scalds |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112843193A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023156069A1 (en) * | 2022-02-18 | 2023-08-24 | The Boots Company Plc | Cosmetic composition comprising extract of ophiopogon japonicus and at least one ceramide |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283887A (en) * | 2011-09-07 | 2011-12-21 | 王全英 | Ointment for treating burn |
| CN104825680A (en) * | 2015-05-19 | 2015-08-12 | 王之学 | Traditional Chinese medicine ointment for treating burn injury |
-
2020
- 2020-11-24 CN CN202011328397.9A patent/CN112843193A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283887A (en) * | 2011-09-07 | 2011-12-21 | 王全英 | Ointment for treating burn |
| CN104825680A (en) * | 2015-05-19 | 2015-08-12 | 王之学 | Traditional Chinese medicine ointment for treating burn injury |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023156069A1 (en) * | 2022-02-18 | 2023-08-24 | The Boots Company Plc | Cosmetic composition comprising extract of ophiopogon japonicus and at least one ceramide |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432536B (en) | Traditional Chinese medicine composition for treating acne and preparation method thereof | |
| CN102178809A (en) | Externally-applied medicament for skin and method for processing medicament into preparation | |
| CN105412650A (en) | Medicine for treating dermatophytosis | |
| CN106620539A (en) | External ointment for treating skin diseases as well as preparation method and application thereof | |
| CN103623182B (en) | Medicine for treating gynecological inflammations and preparation method thereof | |
| CN106668274A (en) | Externally-used traditional Chinese medicine health care preparation with beauty treatment, pain relief and itching relief and preparation method thereof | |
| CN101229322A (en) | External medicine for treating surgery and dermatology department diseases and preparing method thereof | |
| CN102327454A (en) | Chinese herbal medicine for treating pars superficialis abscess | |
| CN102626505B (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN112843193A (en) | Skin rejuvenation liquid for treating burns and scalds | |
| CN104940627A (en) | Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition | |
| CN102552737B (en) | Quick and effective bleeding arresting Chinese medicinal tincture | |
| CN104984148A (en) | Traditional Chinese medicine composite for wound care in clinical application | |
| CN105582475A (en) | Nursing disinfectant for obstetrics and gynecology department and preparation method of nursing disinfectant | |
| CN104352914A (en) | Care solution used after hemorrhoidectomy | |
| CN105596742B (en) | A topical Chinese medicinal ointment for treating burn and scald, and its preparation method | |
| CN1444976A (en) | Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method | |
| CN104922449A (en) | Traditional Chinese medicine disinfection solution and preparation method thereof | |
| CN110448666B (en) | A formula essential oil for treating burns and scalds | |
| CN116726127B (en) | A traditional Chinese medicine gel for repairing wound surface after anal fistula surgery and preparation method thereof | |
| CN102204977A (en) | Preparation method and application of ointment composition for external use for treating tubal nowhere | |
| CN105560581A (en) | Traditional Chinese medicine tincture for treating chilblain and preparation method thereof | |
| CN104758830A (en) | Traditional Chinese medicine composition for treating bone disease and skin injury and preparation method of traditional Chinese medicine composition | |
| CN104436043A (en) | Analgesic anti-inflammatory ointment for treating sore and ulcer yang syndrome and preparation method thereof | |
| CN105012503A (en) | Ointment for treating scalding and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20210528 |
|
| WD01 | Invention patent application deemed withdrawn after publication |